Aevi Genomic Medicine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GNMX and buy or sell other stocks, ETFs, and their options commission-free!About GNMX
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies.
CEOMichael F. Cola
CEOMichael F. Cola
Employees—
Employees—
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2000
Founded2000
Employees—
Employees—
GNMX Key Statistics
Market cap12.89M
Market cap12.89M
Price-Earnings ratio-0.56
Price-Earnings ratio-0.56
Dividend yield—
Dividend yield—
Average volume2.46M
Average volume2.46M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.347
52 Week high$0.347
52 Week low$0.11
52 Week low$0.11
Stock Snapshot
With a market cap of 12.89M, Aevi Genomic Medicine(GNMX) trades at $0.17. The stock has a price-to-earnings ratio of -0.56.
Aevi Genomic Medicine(GNMX) stock opened on 2025-12-17 at —. The price climbed to — and dipped to —.
Aevi Genomic Medicine(GNMX) shares are trading with a volume of 0, against a daily average of 2.46M.
During the past year, Aevi Genomic Medicine(GNMX) stock moved between $0.11 at its lowest and $0.35 at its peak.
During the past year, Aevi Genomic Medicine(GNMX) stock moved between $0.11 at its lowest and $0.35 at its peak.